Lv4
560 积分 2025-04-25 加入
Chemotherapy with or without pembrolizumab followed by maintenance pembrolizumab with or without olaparib as first-line treatment of patients with advanced BRCA non-mutated epithelial ovarian cancer (ENGOT-OV43/GOG-3036/KEYLYNK-001): a randomised, double-blind, placebo-controlled, phase 3 trial
16天前
已完结
The Child's Conception of Space
1个月前
已完结
Egocentrism in adolescence
1个月前
已完结
NEOADJUVANT CHEMOTHERAPY PLUS CADONILIMAB FOLLOWED BY FERTILITY-SPARING SURGERY IN YOUNG PATIENTS WITH CERVICAL CANCER: A PHASE II STUDY
3个月前
已关闭
The validity of the subsequent pregnancy index score for fertility-sparing trachelectomy in early-stage cervical cancer
3个月前
已完结
Endometrial cancer: A Society of Gynecologic Oncology evidence-based review and recommendations, part II
5个月前
已完结
The challenge of molecular stratification in No Specific Molecular Profile endometrial cancer
7个月前
已完结
Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
8个月前
已完结
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial
9个月前
已完结
Opportunistic Salpingectomy for Prevention of Tubo-Ovarian Carcinoma
9个月前
已关闭